These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30622220)

  • 1. USP4 deficiency exacerbates hepatic ischaemia/reperfusion injury via TAK1 signalling.
    Zhou J; Qiu T; Wang T; Chen Z; Ma X; Zhang L; Zou J
    Clin Sci (Lond); 2019 Jan; 133(2):335-349. PubMed ID: 30622220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-Specific Peptidase 10 Protects Against Hepatic Ischaemic/Reperfusion Injury via TAK1 Signalling.
    Jiangqiao Z; Tianyu W; Zhongbao C; Long Z; Jilin Z; Xiaoxiong M; Tao Q
    Front Immunol; 2020; 11():506275. PubMed ID: 33133065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripartite Motif 8 Deficiency Relieves Hepatic Ischaemia/reperfusion Injury via TAK1-dependent Signalling Pathways.
    Tao Q; Tianyu W; Jiangqiao Z; Zhongbao C; Xiaoxiong M; Long Z; Jilin Z
    Int J Biol Sci; 2019; 15(8):1618-1629. PubMed ID: 31360105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination.
    Chen Z; Hu F; Zhang Y; Zhang L; Wang T; Kong C; Hu H; Guo J; Chen Q; Yu B; Liu Y; Zou J; Zhou J; Qiu T
    Front Immunol; 2023; 14():1167667. PubMed ID: 37304282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tripartite Motif-Containing 27 Attenuates Liver Ischemia/Reperfusion Injury by Suppressing Transforming Growth Factor β-Activated Kinase 1 (TAK1) by TAK1 Binding Protein 2/3 Degradation.
    Chen SY; Zhang HP; Li J; Shi JH; Tang HW; Zhang Y; Zhang JK; Wen PH; Wang ZH; Shi XY; He YT; Hu BW; Yang H; Guo WZ; Zhang SJ
    Hepatology; 2021 Feb; 73(2):738-758. PubMed ID: 32343849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-Transmembrane Epithelial Antigen of the Prostate 3 Deficiency in Hepatocytes Protects the Liver Against Ischemia-Reperfusion Injury by Suppressing Transforming Growth Factor-β-Activated Kinase 1.
    Guo WZ; Fang HB; Cao SL; Chen SY; Li J; Shi JH; Tang HW; Zhang Y; Wen PH; Zhang JK; Wang ZH; Shi XY; Pang C; Yang H; Hu BW; Zhang SJ
    Hepatology; 2020 Mar; 71(3):1037-1054. PubMed ID: 31393024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice.
    Zhao Y; Wang F; Gao L; Xu L; Tong R; Lin N; Su Y; Yan Y; Gao Y; He J; Kong L; Yuan A; Zhuge Y; Pu J
    Hepatology; 2018 Sep; 68(3):897-917. PubMed ID: 29573006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation.
    Fan YH; Yu Y; Mao RF; Tan XJ; Xu GF; Zhang H; Lu XB; Fu SB; Yang J
    Cell Death Differ; 2011 Oct; 18(10):1547-60. PubMed ID: 21331078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TRAF3 signaling protects against hepatic ischemia/reperfusions injury.
    Hu J; Zhu XH; Zhang XJ; Wang PX; Zhang R; Zhang P; Zhao GN; Gao L; Zhang XF; Tian S; Li H
    J Hepatol; 2016 Jan; 64(1):146-59. PubMed ID: 26334576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation.
    Zhang JK; Ding MJ; Liu H; Shi JH; Wang ZH; Wen PH; Zhang Y; Yan B; Guo DF; Zhang XD; Tao RL; Yan ZP; Zhang Y; Liu Z; Guo WZ; Zhang SJ
    Hepatology; 2022 Feb; 75(2):338-352. PubMed ID: 34455616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK1 ubiquitination regulates doxorubicin-induced NF-κB activation.
    Liang L; Fan Y; Cheng J; Cheng D; Zhao Y; Cao B; Ma L; An L; Jia W; Su X; Yang J; Zhang H
    Cell Signal; 2013 Jan; 25(1):247-54. PubMed ID: 22981905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CARD3 Promotes Cerebral Ischemia-Reperfusion Injury Via Activation of TAK1.
    Wu X; Lin L; Qin JJ; Wang L; Wang H; Zou Y; Zhu X; Hong Y; Zhang Y; Liu Y; Xin C; Xu S; Ye S; Zhang J; Xiong Z; Zhu L; Li H; Chen J; She ZG
    J Am Heart Assoc; 2020 May; 9(9):e014920. PubMed ID: 32349637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression.
    Wang X; Mao W; Fang C; Tian S; Zhu X; Yang L; Huang Z; Li H
    J Hepatol; 2017 Sep; ():. PubMed ID: 28887166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPRO plays a dual role in hepatic ischemia reperfusion injury through feedback activation of NF-κB.
    Hou J; Xia Y; Jiang R; Chen D; Xu J; Deng L; Huang X; Wang X; Sun B
    J Hepatol; 2014 Feb; 60(2):306-12. PubMed ID: 24128416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.
    Yang L; Wang W; Wang X; Zhao J; Xiao L; Gui W; Fan H; Xia J; Li Z; Yan J; Alasbahi A; Zhu Q; Hou X
    Hepatology; 2019 Jan; 69(1):294-313. PubMed ID: 30076625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. USP10 protects against cerebral ischemia injury by suppressing inflammation and apoptosis through the inhibition of TAK1 signaling.
    Wang L; Wu D; Xu Z
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1272-1278. PubMed ID: 31301769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia-reperfusion injury via TAK1-JNK/p38 pathway.
    Zhang Z; Ma T; Fu Z; Feng Y; Wang Z; Tian S; Liu Z; Wei W; Li X; Chen J; Zhao W
    J Neurochem; 2022 Feb; 160(3):392-411. PubMed ID: 34837397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-142-3p attenuates hepatic ischemia/reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate.
    Li Y; Gao M; Xu LN; Yin LH; Qi Y; Peng JY
    Pharmacol Res; 2020 Jun; 156():104783. PubMed ID: 32224251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial-specific depletion of TAK1 is neuroprotective in the acute phase after ischemic stroke.
    Zeyen T; Noristani R; Habib S; Heinisch O; Slowik A; Huber M; Schulz JB; Reich A; Habib P
    J Mol Med (Berl); 2020 Jun; 98(6):833-847. PubMed ID: 32382778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
    Wu YK; Hu LF; Lou DS; Wang BC; Tan J
    Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.